• Addendum: Considerations for Conducting Rapid Community Assessment in Migrant and Seasonal Farmworker Communities Cite CITE Title : Addendum: Considerations for Conducting Rapid Community Assessment in Migrant and Seasonal Farmworker Communities Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : January 2022 Series : Vaccinate with confidence URL : https://stacks.cdc.gov/view/cdc/133550 Centers for Disease Control and Prevention (U.S.) (2022). Addendum: Considerations for Conducting Rapid Community Assessment in Migrant and Seasonal Farmworker Communities. Centers for Disease Control and Prevention (U.S.) "Addendum: Considerations for Conducting Rapid Community Assessment in Migrant and Seasonal Farmworker Communities" (2022) Centers for Disease Control and Prevention (U.S.) "Addendum: Considerations for Conducting Rapid Community Assessment in Migrant and Seasonal Farmworker Communities" , 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.32 MB] : Centers for Disease Control and Prevention (U.S.) January 2022 | Vaccinate with confidence Description: This document outlines considerations and guidelines for working with migrant and seasonal farmworkers (MSFWs) as part of a Rapid Community Assessment... File Type: [PDF - 1.32 MB] File Type: [PDF - 1.32 MB] Di(2-etilhexil) ftalato (DEHP) Cite CITE Title : Di(2-etilhexil) ftalato (DEHP) Corporate Authors(s) : United States. Agency for Toxic Substances and Disease Registry. Published Date : Septiembre 2002 Series : ToxFAQs URL : https://stacks.cdc.gov/view/cdc/113702 United States. Agency for Toxic Substances and Disease Registry. (2002). Di(2-etilhexil) ftalato (DEHP). United States. Agency for Toxic Substances and Disease Registry. "Di(2-etilhexil) ftalato (DEHP)" (2002) United States. Agency for Toxic Substances and Disease Registry. "Di(2-etilhexil) ftalato (DEHP)" , 2002 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 269.77 KB] : United States. Agency for Toxic Substances and Disease Registry. Septiembre 2002 | ToxFAQs Description: Esta hoja informativa contesta las preguntas más frecuentes acerca de los efectos del di(2-etilhexil)ftalato (DEHP) sobre la salud. Para más infor... File Type: [PDF - 269.77 KB] File Type: [PDF - 269.77 KB] Di(2-ethylhexyl)phthalate (DEHP) - ToxFAQs Cite CITE Title : Di(2-ethylhexyl)phthalate (DEHP) - ToxFAQs Corporate Authors(s) : United States. Agency for Toxic Substances and Disease Registry. Office of Innovation and Analytics. Toxicology Section. Published Date : January 2022 Series : ToxFAQs URL : https://stacks.cdc.gov/view/cdc/113703 United States. Agency for Toxic Substances and Disease Registry. Office of Innovation and Analytics. Toxicology Section. (2022). Di(2-ethylhexyl)phthalate (DEHP) - ToxFAQs. United States. Agency for Toxic Substances and Disease Registry. Office of Innovation and Analytics. Toxicology Section. "Di(2-ethylhexyl)phthalate (DEHP) - ToxFAQs" (2022) United States. Agency for Toxic Substances and Disease Registry. Office of Innovation and Analytics. Toxicology Section. "Di(2-ethylhexyl)phthalate (DEHP) - ToxFAQs" , 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 154.25 KB] : United States. Agency for Toxic Substances and Disease Registry. Office of Innovation and Analytics. Toxicology Section. January 2022 | ToxFAQs No Description File Type: [PDF - 154.25 KB] File Type: [PDF - 154.25 KB] Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022 Cite CITE Title : Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022 Personal Author(s) : Thompson, Mark G.;Natarajan, Karthik;Irving, Stephanie A.;Rowley, Elizabeth A.;Griggs, Eric P.;Gaglani, Manjusha;Klein, Nicola P.;Grannis, Shaun J.;DeSilva, Malini B.;Stenehjem, Edward;Reese, Sarah E.;Dickerson, Monica;Naleway, Allison L.;Han, Jungmi;Konatham, Deepika;McEvoy, Charlene;Rao, Suchitra;Dixon, Brian E.;Dascomb, Kristin;Lewis, Ned;Levy, Matthew E.;Patel, Palak;Liao, I-Chia;Kharbanda, Anupam B.;Barron, Michelle A.;Fadel, William F.;Grisel, Nancy;Goddard, Kristin;Yang, Duck-Hye;Wondimu, Mehiret H.;Murthy, Kempapura;Valvi, Nimish R.;Arndorfer, Julie;Fireman, Bruce;Dunne, Margaret M.;Embi, Peter;Azziz-Baumgartner, Eduardo;Zerbo, Ousseny;Bozio, Catherine H.;Reynolds, Sue;Ferdinands, Jill;Williams, Jeremiah;Link-Gelles, Ruth;Schrag, Stephanie J.;Verani, Jennifer R.;Ball, Sarah;Ong, Toan C.; Corporate Authors(s) : CDC COVID-19 Response Team;Columbia University Dept. of Biomedical Informatics;New York Presbyterian Hospital;Center for Health Research (Kaiser-Permanente Medical Care Program Northwest Region);Texas A&M University College of Medicine Baylor Scott & White Health;Kaiser Permanente Vaccine Study Center;Regenstrief Institute for Health Care‏;Center for Biomedical Informatics;Indiana University Richard M. Fairbanks School of Public Health;HealthPartners Institute;Intermountain Healthcare, UT;Div. of Infectious Diseases and Clinical Epidemiology;University of Colorado Anschutz Medical Campus Dept. of Medicine;Indiana University Fairbanks School of Public Health;Vanderbilt University;VISION Network; Published Date : January 21, 2022 Series : MMWR; v. 71, ER, 1/21/22 URL : https://stacks.cdc.gov/view/cdc/113718 Thompson, Mark G. et al. (2022). Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022. 71 Thompson, Mark G. et al. "Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022" 71 (2022) Thompson, Mark G. et al. "Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron Variants predominance — VISION Network, 10 States, August 2021–January 2022" vol. 71, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 417.21 KB] Personal Author: Thompson, Mark G. ; Natarajan, Karthik ... January 21, 2022 | MMWR; v. 71, ER, 1/21/22 Description: What is already known about this topic? COVID-19 mRNA vaccine effectiveness (VE) in preventing COVID-19 might decline because of waning of vaccine-ind... File Type: [PDF - 417.21 KB] File Type: [PDF - 417.21 KB] Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts Cite CITE Title : Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : November 2021 Series : Vaccinate with confidence URL : https://stacks.cdc.gov/view/cdc/113699 Centers for Disease Control and Prevention (U.S.) (2021). Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts. Centers for Disease Control and Prevention (U.S.) "Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts" (2021) Centers for Disease Control and Prevention (U.S.) "Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts" , 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 898.96 KB] : Centers for Disease Control and Prevention (U.S.) November 2021 | Vaccinate with confidence Description: This document outlines considerations and guidelines for working with adolescent populations (12–17 years old) and gathering information from digita... File Type: [PDF - 898.96 KB] File Type: [PDF - 898.96 KB] COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021 Cite CITE Title : COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021 Personal Author(s) : Johnson, Amelia G.;Amin, Avnika B.;Ali, Akilah R.;Hoots, Brooke;Cadwell, Betsy L.;Arora, Shivani;Avoundjian, Tigran;Awofeso, Abiola O.;Barnes, Jason;Bayoumi, Nagla S.;Busen, Katherine;Chang, Carolyn;Cima, Mike;Crockett, Molly;Cronquist, Alicia;Davidson, Sherri;Davis, Elizabeth;Delgadill0, Janelle;Dorabawila, Vajeera;Drenzek, Cherie;Eisenstein, Leah;Fast, Hannah E.;Gent, Ashley;Hand, Julie;Hoefer, Dina;Holtzman, Corinne;Jara, Amanda;Jones, Amanda;Kamal-Ahmed, Ishrat;Kangas, Sarah;Kanishka, FNU;Kaur, Ramandeep;Khan, Saadiah;King, Justice;Kirkendall, Samantha;Klioueva, Anna;Kocharian, Anna;Kwon, Frances Y.;Logan, Jacqueline;Lyons, B. Casey;Lyons, Shelby;May, Andrea;McCormick, Donald;Mendoza, Erica;Milroy, Lauren;O’Donnell, Allison;Pike, Melissa;Pogosjans, Sargis;Saupe, Amy;Sell, Jessica;Smith, Elizabeth;Sosin, Daniel M.;Stanislawski, Emma;Steele, Molly K.;Stephenson, Meagan;Stout, Allen;Strand, Kyle;Tilakaratne, Buddhi P.;Turner, Kathryn;Vest, Hailey;Warner, Sydni;Wiedeman, Caleb;Zaldivar, Allison;Silk, Benjamin J.;Scobie, Heather M.; Corporate Authors(s) : CDC COVID-19 Emergency Response Team Epidemiology Task Force;Rhode Island Dept. of Health;Seattle & King County Dept. of Public Health;District of Columbia Dept. of Health;Utah Dept. of Health;New Jersey Dept. of Health;Michigan. Dept. of Health and Human Services;New York, NY Dept. of Health and Mental Hygiene;Arkansas Dept. of Health;MassachU.S.etts Dept. of Public Health;Colorado Dept. of Public Health and Environment;Alabama Dept. of Public Health;New Mexico Dept. of Health;New York State Dept. of Health;Georgia Dept. of Public Health;Florida Dept. of Health;COVID-19 Response Team Vaccine Task Force;Louisiana Dept. of Health;Minnesota Dept. of Health;Center for Surveillance, Epidemiology, and Laboratory Services (U.S.);Nebraska Dept. of Health and Human Services;Wisconsin Dept. of Health Services;Idaho Dept. of Health and Welfare;Texas Dept. of State Health Services;Tennessee Dept. of Health;CDC COVID-19 Emergency Response Team Data Analytics and Visualization Task Force;Kansas Dept. of Health and Environment;Indiana Dept. of Health; Published Date : January 21, 2022 Series : MMWR; v. 71, ER, 1/21/22 URL : https://stacks.cdc.gov/view/cdc/113717 Johnson, Amelia G. et al. (2022). COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021. 71 Johnson, Amelia G. et al. "COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021" 71 (2022) Johnson, Amelia G. et al. "COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of Delta and Omicron Variants emergence — 25 U.S. jurisdictions, April 4–December 25, 2021" vol. 71, 2022 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 493.78 KB] Personal Author: Johnson, Amelia G. ; Amin, Avnika B. ... January 21, 2022 | MMWR; v. 71, ER, 1/21/22 Description: What is already known about this topic? Although COVID-19 vaccine effectiveness decreased with emergence of the Delta Variants and waning of vaccine-i... File Type: [PDF - 493.78 KB] File Type: [PDF - 493.78 KB] Addendum: Considerations for conducting rapid community assessment in tribal communities Cite CITE Title : Addendum: Considerations for conducting rapid community assessment in tribal communities Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : November 2021 Series : Vaccinate with confidence URL : https://stacks.cdc.gov/view/cdc/113700 Centers for Disease Control and Prevention (U.S.) (2021). Addendum: Considerations for conducting rapid community assessment in tribal communities. Centers for Disease Control and Prevention (U.S.) "Addendum: Considerations for conducting rapid community assessment in tribal communities" (2021) Centers for Disease Control and Prevention (U.S.) "Addendum: Considerations for conducting rapid community assessment in tribal communities" , 2021 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 990.82 KB] : Centers for Disease Control and Prevention (U.S.) November 2021 | Vaccinate with confidence Description: This document outlines considerations and guidelines for working with Tribal Communities as part of a Rapid Community Assessment (RCA).CDC-RCA-Guide-T... File Type: [PDF - 990.82 KB] File Type: [PDF - 990.82 KB]

More +